Guest: John Kirkpatrick, MD, PhD

Guest: John Sampson, MD, PhD, MHSC, MBA

CME Information FacultyJohn Kirkpatrick, MD, PhD Associate Professor of Radiation Oncology and SurgeryDuke University Health System Durham, NC John Sampson, MD, PhD, MHSC, MBARobert H. Wilkins and Gloria Wilkins Professor of NeurosurgeryChair, Department of NeurosurgeryDuke University Health System Durham, NC Activity PlannersMeghan Coulehan, MPHManager, Educational Strategy and ContentMed-IQBaltimore, MD Amy SisonDirector of Continuing Medical EducationMed-IQBaltimore, MD Activity OverviewIn this engaging discussion-based Webcast, two prominent Duke oncology clinicians—a neurosurgeon and a radiation oncologist—explain the currently available options and clinical guidelines for treating brain metastases. The benefits, limitations, and indications for surgery, stereotactic radiosurgery, and whole-brain radiation therapy are reviewed, as well as patient characteristics that factor into treatment selection. Learning ObjectivesUpon completion, participants should be able to: Understand the benefits, limitations, and indications for use of radiosurgery, neurosurgery, and whole-brain radiation therapy for brain metastases Discuss the role of combination and adjuvant therapies in the treatment of metastatic disease Explain the individual patient- and disease-related factors that should be considered when planning treatment for brain metastases Target AudienceThis activity is intended primarily for physicians, nurse practitioners, physician assistants, nurses, and pharmacists. Statement of NeedMore than 250,000 cases of brain metastasis are diagnosed annually, and metastasis occurs in 20% to 40% of ...